Catalyst
  • LatticePoint

    Created in 2015
  • Social networks

    2,378 93
  • Location

    Cr de Rive 13, 1204 Genève, Switzerland

    Genève

    Switzerland

  • Engaged entities

    10
    0 0
  • Added in Motherbase

    21 Sep 2022, 4:20 p.m.
Description
  • Value proposition

    LatticePoint is a boutique consulting firm focused on pricing and market access for pharmaceutical & biotech companies

    LatticePoint is a boutique consulting firm that focuses on pricing and market access for innovative medicines and medical devices. LatticePoint is led by former industry market access leaders who understand how to plan for the political, scientific, and financial realities that will be pivotal in negotiating product access. We work with biopharma companies and investors to help define, negotiate, and defend the value of their products in key markets around the world.

    The LatticePoint team has over 40 years of pharmaceutical and biotechnology industry experience. Led by former industry market access leaders and a high-caliber team with significant experience in the sciences, licensing, M&A due diligence and integration, venture capital and international affiliate operations, we have a depth of experience not seen in most consultancies. We can efficiently and accurately define a medicine’s value; and have our team ready to create the right strategy whether you are raising capital, in-licensing, launching or preparing for competition.

    At LatticePoint, we have in-country experience working with, and on behalf of, our clients who require on-the-ground assistance. Our multilingual staff of native German, French, Italian, Spanish, Portuguese and English speakers is experienced at handling negotiations in many key countries while keeping an eye on cross-border implications. We engage with payers, providers, hospitals, HTA bodies and EMA for early access, give feedback on clinical program design, and create and execute in-country reimbursement strategy negotiations in key markets around the world. We retain a Global Payer Panel for market research interviews.

    pricing, market access, competition, and product strategy

Entity interactions
Entity Type Tweets Articles
MedWatch MedWatch
Online Audio and Video Media (Auto)
Other

21 Feb 2026


Copenhagen Capacity Copenhagen Capacity
International Trade and Development (Auto)
Other

27 Feb 2026


Eisai EMEA Eisai EMEA
Pharmaceutical Manufacturing (Auto)
Other

14 Nov 2025


ISPOR—The Professional Society for Health Economics and Outcomes Research ISPOR—The Professional Society for Health Economics and Outcomes Research
healthtech, Hospitals and Health Care (Auto)
Other

30 Nov 2024


Biotechgate Biotechgate
biotech, deeptech, Biotechnology Research (Auto)
Other

30 Apr 2024


Barcelona Institute of Science and Technology (BIST) Barcelona Institute of Science and Technology (BIST)
deeptech, Research Services (Auto)
Other

2 Jul 2023


Les Echos Les Echos
Newspaper Publishing (Auto)
Other

10 Feb 2012


Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
biotech, deeptech, Book and Periodical Publishing (Auto)
Other

2 Oct 2013


Reuters Reuters
Other

25 Feb 2011


University of Geneva University of Geneva
deeptech, Research Services (Auto)
Other

17 Mar 2020


Radars
Loading...